Clinical trials for cellular therapy products: conclusions reached by foreign regulatory bodies
Currently, the problem of adopting viable human cell-based drugs – biomedical cell products (BCPs) – in medical practice in the Russian Federation includes, among others, lack of experience in clinical trials for such drugs and insufficient expert assessment under the national state registration pro...
|Main Authors:||, ,|
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
|Series:||Vestnik Transplantologii i Iskusstvennyh Organov|